参考文献/References:
[1] Trombetta MG, Colonias A, Makishi D, et al. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung[J]. Brachytherapy, 2008, 7(1):50-54.
[2] Chassagne D, Court B, Gerbaulet A, et al. Cancer of the prostate:technics of curietherapy. Review of the literature and experience at the Institut Gustave-Roussy[J]. Bull Cancer, 1985, 72(6):578-584.
[3] 于香红, 李振家, 窦卫涛, 等. CT引导下125I放射性粒子植入治疗隔顶部原发性肝癌价值的探讨[J]. 医学影像学杂志, 2013, 23(10):1575-1578.
[4] Older RA, Synder B, Krupski TL, et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy[J]. J Urol, 2001, 165(5):1590-1592.
[5] Darakchiev BJ, Albright RE, Breneman JC, et al. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme[J]. J Neurosurg, 2008, 108(2):236-242.
[6] 杨景魁, 吕金爽, 阎卫亮, 等. 放射性粒子植入治疗不能手术的早期非小细胞肺癌疗效分析[J]. 中国肿瘤临床, 2014, 41(17):1111-1114.
[7] Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation[J]. Int J Radiat Oncol Biol Phys, 2007, 67(2):327-333.
[8] 柴树德, 王俊杰, 申文江, 等. 放射性粒子植入治疗胸部肿瘤[M]. 天津:天津科学技术出版社, 2007:37-39.
[9] 王娟, 王绍其, 徐建彬, 等. 125I粒子不同分布组织间植入对荷人胃癌裸鼠移植瘤疗效的影响[J]. 中华核医学杂志, 2008, 28(5):313-316.
[10] Liao A, Wang J, Wang J, et al. Relative biological effectiveness and cell-killing efficacy of continuous low-dose-rate 125I seeds on prostate carcinoma cells in vitro[J]. Integr Cancer Ther, 2010, 9(1):59-65.
[11] 谈瑞生, 朱永强, 施富强, 等. CT引导下125I放射性粒子植入治疗恶性肿瘤19例分析[J]. 重庆医学, 2014, 43(1):106-109.
[12] 李振家, 王锡明, 武乐斌, 等. CT导向下组织间植入125I粒子治疗胰腺癌[J]. 中华肿瘤杂志, 2005, 27(3):187.
[13] No authors listed. Cancer statistics[J]. JAMA, 2013, 310(9):982.
[14] Yoshioka Y. Current statue and perspectives of brachytherapy for prostate cancer[J]. Int J Clin Oncol, 2009, 14(1):31-36.
[15] 吕金爽, 杨景魁, 郑广钧, 等. CT引导下放射性粒子植入治疗恶性纤维组织细胞瘤肺转移瘤临床疗效研究[J]. 中国肿瘤临床, 2013, 40(7):407-409.
[16] 王俊杰, 田素青, 李金娜, 等. 放射性125I粒子平面永久插植布源剂量分布研究[J]. 中国微创外科杂志, 2005(12):1061-1062.
[17] Pickett B, Pouliot J. The effect of the radial function on 125I seeds used for permanent prostate implantation[J]. Med Dosim, 2004, 29(3):204-209.
[18] 杨文彬, 王磊, 刘娜, 等. 局部碘-125放射性粒子植入治疗胰腺癌的疗效评价[J]. 西安交通大学学报:医学版, 2011, 32(4):481-486.
[19] 林征宇, 武乐斌, 李成利, 等. 光学导航介入性MR的临床应用[J]. 中华放射学杂志, 2005, 39(7):740-742.
[20] Yen TL, Driscoll CL, Lalwani AK. Significance of House-Brackmann facial nerve grading global score in the setting of differential facial nerve function[J]. Otol Neurotol, 2003, 24(1):118-122.
[21] Ling CC. Permanent implants using I-125 radiobiological consider-rations based on the linear quadratic model[J]. Int J Radiat Oncol Biol Phys, 1992, 23(1):81-87.
[22] 田素青. 放射性粒子永久植入治疗非小细胞肺癌的研究[J]. 国际放射医学核医学杂志, 2007, 31(3):188-191.
[23] 张建国, 张杰, 宋铁砾, 等. 125I放射性粒子组织间植入治疗面神经受侵的腮腺恶性肿瘤初步临床观察[J]. 中华口腔医学杂志, 2008, 43(3):132-135.
[24] Park RL, Liberman FZ, Lee DL, et al. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell can-cer of the head and neck[J]. Laryngoscope, 1991, 101(4 Pt1):405-410.
[25] 王娟, 张宏涛, 赵文清, 等. 125I粒子平面布源剂量学研究[J]. 中华核医学杂志, 2010, 30(5):339-342.
[26] Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachyther-apy in the treatment of colorectal adenocarcinoma metastatic to the liver[J]. Cancer, 1999, 85(6):1218-1225.
[27] Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer:observed local control with implantation of I-125 brachytherapy seeds[J]. Ann Thorae Surg, 2003, 75(1):237-242.
[28] Lee EK, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implant[J]. Int J Radiat Oncol Biol Phys, 2003, 56(3):854-861.
[29] 翁志成, 杨维竹, 江娜, 等. CT引导下125I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J]. 介入放射学杂志, 2010, 19(7):535-539.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]田琦,张丽花,蒋宁一.甲状腺癌131I治疗后合并骨髓增生异常综合征一例[J].国际放射医学核医学杂志,2016,40(3):235.[doi:10.3760/cma.j.issn.1673-4114.2016.03.014]
[6]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[7]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[10]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[11]甄作武,林坚,杨锦钊,等.影像引导下125Ⅰ粒子组织间植入近距离治疗肿瘤的应用进展[J].国际放射医学核医学杂志,2013,37(2):116.[doi:10.3760/cma.j.issn.1673-4114.2013.02.014]
ZHEN Zuo-wu,LIN Jian,YANG Jin-zhao,et al.Application and progress of image-guided 125Ⅰ seed interstitial implantation for the treatment of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):116.[doi:10.3760/cma.j.issn.1673-4114.2013.02.014]
[12]张富海,孟召伟,谭建.肺癌的放射性核素分子靶向治疗[J].国际放射医学核医学杂志,2012,36(3):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
ZHANG Fu-hai,MENG Zhao-wei,TAN Jian.Radionuclide molecular target therapy for lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
[13]柳江燕,陈雪红,胡金贵,等.125Ⅰ粒子持续低剂量率杀伤肿瘤细胞体外实验研究进展[J].国际放射医学核医学杂志,2011,35(1):5.[doi:10.3760/cma.j.issn.1673-4114.2011.01.002]
LIU Jiang-yan,CHEN Xue-houg,HU Jin-gui,et al.Advances in the experimental study on continuous low-dose-rate irradiation by 125I seeds killing cancer cell in vitro[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):5.[doi:10.3760/cma.j.issn.1673-4114.2011.01.002]
[14]孙启和,孙彬,杨永青.术中125I粒子植入治疗肿瘤的临床应用[J].国际放射医学核医学杂志,2010,34(2):102.[doi:10.3760/cma.j.issn.1673-4114.2010.02.011]
SUN Qi-he,SUN Bin,YANG Yong-qing.The clinical application of 125I radionuclide implantation in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):102.[doi:10.3760/cma.j.issn.1673-4114.2010.02.011]
[15]荆宏雁.癌症手术治疗中放射性125I粒子源的应用[J].国际放射医学核医学杂志,2008,32(1):58.
[16]张敬勉,赵新明,王建方,等.99Tc-亚甲基二膦酸盐与153Sm-乙二胺四亚甲基膦酸对骨侵袭和骨质溶解抑制作用的对比研究[J].国际放射医学核医学杂志,2008,32(6):321.
ZHANG Jing-mian,ZHAO Xin-ming,WANG Jian-fang,et al.The comparative study of inhibitory effects of 99Tc-methylenediphosphonate and 153Sm-ethylene diamine tetramethylene phosphonic acid on bone invasion and osteolysis[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):321.
[17]胡瑞,林军.125I粒子组织间植入近距离治疗恶性肿瘤[J].国际放射医学核医学杂志,2007,31(6):381.
HU Rui,LIN Jun.Brachytherapy of malignant tumors with interstitial implantation of 125I seed[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):381.
[18]陈志军,涂新华,周爱清,等.125I粒子组织间植入治疗2例恶性肿瘤放化疗失败病例临床分析[J].国际放射医学核医学杂志,2006,30(3):180.
CHEN Zhi-jun,TU Xin-hua,ZHOU Ai-qing,et al.Clinical analysis of 125I seed implants in worst-casts of the malignant tumors after radiography and chemotherapy.[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):180.
[19]于雷,陈红红,程文英,等.放射性籽源薄层片植入治疗肿瘤的研究进展[J].国际放射医学核医学杂志,2006,30(6):369.
YU Lei,CHEN Hong-hong,CHENG Wen-ying,et al.Progress of intraoperative brachytherapy using radioactive seeds plaque implants for tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):369.
[20]黄帆,高阳,张玉民,等.新型渗透性水凝胶作为载体用于肿瘤的放射性核素植入治疗[J].国际放射医学核医学杂志,2017,41(2):81.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]
Huang Fan,Gao Yang,Zhang Yumin,et al.New permeable hydrogel for tumor radiotherapy in situ[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):81.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]